ES2125201B1 - Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias. - Google Patents

Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias.

Info

Publication number
ES2125201B1
ES2125201B1 ES009701389A ES9701389A ES2125201B1 ES 2125201 B1 ES2125201 B1 ES 2125201B1 ES 009701389 A ES009701389 A ES 009701389A ES 9701389 A ES9701389 A ES 9701389A ES 2125201 B1 ES2125201 B1 ES 2125201B1
Authority
ES
Spain
Prior art keywords
diagnosis
allergen
recombinant dna
olea europaea
allergies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009701389A
Other languages
English (en)
Other versions
ES2125201A1 (es
Inventor
Ortega Juan Andres Asturias
Garate Alberto Martinez
Quesada Jorge Martinez
Pelaez Ricardo Palacios
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roxall Medicina Espana SA
Original Assignee
Bial Industrial Farmaceutica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Industrial Farmaceutica SA filed Critical Bial Industrial Farmaceutica SA
Priority to ES009701389A priority Critical patent/ES2125201B1/es
Priority to PCT/ES1998/000174 priority patent/WO1998059051A1/es
Publication of ES2125201A1 publication Critical patent/ES2125201A1/es
Application granted granted Critical
Publication of ES2125201B1 publication Critical patent/ES2125201B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

ADN recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 útil para el diagnóstico y tratamiento de alergias. Se ha clonado ADN recombinante que codifica para epitopos del alergeno mayor de Olea europaea y tiene homología con otros alergenos mayores (Syr v 1 y Lig v 1) de otras especies pertenecientes a la Familia Oleaceae. El polen de estas plantas tiene gran importancia alergénica en la Cuenta Mediterránea. El alergeno recombinante ha sido producido como proteína de fusión con la glutatión-S-transferasa, y posteriormente separado de ésta mediante digestión con trombina. El alergeno producido (rOle e 1) muestra un comportamiento antigénico similar al alergeno natural, pudiendo ser utilizado en diagnóstico e inmunoterapia.
ES009701389A 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias. Expired - Fee Related ES2125201B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES009701389A ES2125201B1 (es) 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias.
PCT/ES1998/000174 WO1998059051A1 (es) 1997-06-24 1998-06-18 Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701389A ES2125201B1 (es) 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias.

Publications (2)

Publication Number Publication Date
ES2125201A1 ES2125201A1 (es) 1999-02-16
ES2125201B1 true ES2125201B1 (es) 2000-03-16

Family

ID=8299803

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009701389A Expired - Fee Related ES2125201B1 (es) 1997-06-24 1997-06-24 Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias.

Country Status (2)

Country Link
ES (1) ES2125201B1 (es)
WO (1) WO1998059051A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096942A2 (en) * 2001-05-30 2002-12-05 Alk Abello A/S Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0495064T3 (da) * 1990-08-13 2001-10-15 Biomay Prod & Handel Birkepollenallergen P14 til diagnose og terapi af allergiske sygdomme

Also Published As

Publication number Publication date
WO1998059051A1 (es) 1998-12-30
ES2125201A1 (es) 1999-02-16

Similar Documents

Publication Publication Date Title
Cabau00f1as et al. Importance of albumin in cross-reactivity among cat, dog and horse allergens.
BR112015013183A2 (pt) proteínas de fusão para uso como aperfeiçoadores imunogênicos para indução de respostas de células t específicas para antígenos
CO2018005306A2 (es) Variantes del factor viii reducido con cpg, composiciones y métodos y usos para el tratamiento de trastornos de la hemostasia
HRP20020721B1 (en) Novel method for down-regulation of amyloid
ATE444360T1 (de) T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
AR030307A1 (es) Peptidos de promiostatina y metodos para utilizarlos
PE20110023A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
AR049014A1 (es) Mimeticuerpos de glp-1 humanos , composiciones y usos
CO5560581A2 (es) Vacuna de epitopo de celula t beta-amiloide analogo
ECSP099079A (es) Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos
ES2060580T3 (es) Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
RU2014135406A (ru) Модифицированные эпитопы для усиления ответов cd4+ т-клеток
PE20211494A1 (es) Peptidos inmunogenicos con motivos de oxidorreductasa mejorados
EA201892643A1 (ru) Способ очистки и активации ботулинического нейротоксина
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
ES2125201B1 (es) Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias.
DE60132427D1 (de) Gebrauch von opri lipoprotein aus pseudomonas als th1 induzierendes natürliches adjuvans für heterologe antigene
AR034351A1 (es) Composiciones y metodos para aumentar la tolerancia a stress en plantas
ES2090357T3 (es) Una proteina de union a colageno asi como su preparacion.
TW200504216A (en) Immunization of fish with plant-expressed recombinant proteins
ES2085163T3 (es) Vacunas contra los parasitos metazoos.
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
AR114291A1 (es) Conjugados de péptido tirosina tirosina cíclico con péptido de fusión del péptido similar al glucagón tipo 1 (glp-1) acoplado y usos de estos
AR025198A1 (es) Compuestos para el tratamiento de trastornos infecciosos y del sistema inmune y metodos para su uso

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990216

Kind code of ref document: A1

Effective date: 19990216

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20180807